Yahoo Finance Live's Julie Hyman discusses Blue Water Vaccine stock performance after the U.S. government announced plans for its own monkeypox vaccine.
JULIE HYMAN: All right. Well, I want to take a look at another stock that we're watching, a trending ticker, Blue Water Vaccines. Now, the stock soared yesterday when I was not here but I know that you were watching it, Sozz, when it announced plans that it plans to potentially develop a monkey pox vaccine.
But the shares are pulling back big time today. And now, the government is announcing some new news on monkey pox vaccines, saying it's going to make 1.8 million doses of the existing vaccine on the market available. Because there is an existing vaccine that's available on the market.
So basically, the US government formulating a new plan to try to attack what's going on here in terms of monkeypox. I think that the Health and Human Services Secretary also just announced there are 13,500 cases of monkeypox that have occurred in the United States.
- And we'll add this disclaimer. I think the stock was up close to 200% yesterday. But you've been covering biotech for some time. These are very, very volatile names. And you can see that momentum--
JULIE HYMAN: So volatile that the dollar sign is on the-- Is the dollar sign always on the right side?
- Well, maybe that's--
JULIE HYMAN: Did I miss something here?
- --the hip new thing to do. But look, these stocks are very volatile. They're some of the most popular tickers right now on our site. But again, do your homework before even considering nibbling at any of these.
JULIE HYMAN: That second one that we showed, by the way, is the one that actually has the vaccine out, that is being acquired by the government.